WO2009044439A1 - Composition for preventing or treating liver disease - Google Patents

Composition for preventing or treating liver disease Download PDF

Info

Publication number
WO2009044439A1
WO2009044439A1 PCT/JP2007/069180 JP2007069180W WO2009044439A1 WO 2009044439 A1 WO2009044439 A1 WO 2009044439A1 JP 2007069180 W JP2007069180 W JP 2007069180W WO 2009044439 A1 WO2009044439 A1 WO 2009044439A1
Authority
WO
WIPO (PCT)
Prior art keywords
aqueous
composition
preventing
salt solution
liver disease
Prior art date
Application number
PCT/JP2007/069180
Other languages
French (fr)
Japanese (ja)
Inventor
Shigeo Kono
Original Assignee
Shigeo Kono
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shigeo Kono filed Critical Shigeo Kono
Priority to PCT/JP2007/069180 priority Critical patent/WO2009044439A1/en
Priority to JP2009535898A priority patent/JP5194022B2/en
Publication of WO2009044439A1 publication Critical patent/WO2009044439A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

It is intended to provide a composition for preventing or treating liver disease including liver cancer, which has no adverse effect and is easily taken, and a food or food material having the composition blended therein. A special salt, sale de tierra, is used as an active ingredient of the composition for preventing or treating liver disease. The sale de tierra is obtained by bringing a naturally occurring ion exchanger such as zeolite (mordenite) into contact with an aqueous sodium salt solution, an aqueous potassium salt solution, an aqueous calcium salt solution, an aqueous magnesium salt solution, ammonia water, an aqueous ammonium salt solution, an aqueous inorganic acid solution, an aqueous organic acid solution, sea water, salt lake water or hot spring water to elute components contained in the naturally occurring ion exchanger through ion exchange and subsequently separating the eluate from the naturally occurring ion exchanger. Further, by blending the composition, the food or food material for preventing or treating liver disease is prepared.
PCT/JP2007/069180 2007-10-01 2007-10-01 Composition for preventing or treating liver disease WO2009044439A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2007/069180 WO2009044439A1 (en) 2007-10-01 2007-10-01 Composition for preventing or treating liver disease
JP2009535898A JP5194022B2 (en) 2007-10-01 2007-10-01 Composition for prevention and treatment of liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/069180 WO2009044439A1 (en) 2007-10-01 2007-10-01 Composition for preventing or treating liver disease

Publications (1)

Publication Number Publication Date
WO2009044439A1 true WO2009044439A1 (en) 2009-04-09

Family

ID=40525872

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/069180 WO2009044439A1 (en) 2007-10-01 2007-10-01 Composition for preventing or treating liver disease

Country Status (2)

Country Link
JP (1) JP5194022B2 (en)
WO (1) WO2009044439A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219066A (en) * 1985-07-17 1987-01-27 Shigeo Kono Production of specialty salt
JPH03293002A (en) * 1990-04-10 1991-12-24 Kaoru Kawada Mineral liquid and its extraction method
JP2000007418A (en) * 1998-06-24 2000-01-11 Kazuo Sato Production of ceramic for producing alkalie reduced water using natural zeolite, oyster shells and potassium oxide as raw material
JP2000024663A (en) * 1998-07-14 2000-01-25 Akira Suzuki Electrolytically ionized water generating and purifying device
WO2005041657A1 (en) * 2003-10-20 2005-05-12 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
JP2006083161A (en) * 2004-08-17 2006-03-30 Shigeo Kono Osteogenesis promoter

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219066A (en) * 1985-07-17 1987-01-27 Shigeo Kono Production of specialty salt
JPH03293002A (en) * 1990-04-10 1991-12-24 Kaoru Kawada Mineral liquid and its extraction method
JP2000007418A (en) * 1998-06-24 2000-01-11 Kazuo Sato Production of ceramic for producing alkalie reduced water using natural zeolite, oyster shells and potassium oxide as raw material
JP2000024663A (en) * 1998-07-14 2000-01-25 Akira Suzuki Electrolytically ionized water generating and purifying device
WO2005041657A1 (en) * 2003-10-20 2005-05-12 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
JP2006083161A (en) * 2004-08-17 2006-03-30 Shigeo Kono Osteogenesis promoter

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SUZUKI M. ET AL.: "Alkali Ion-sui o Inyo saseta Koketsuatsu Shizen Hassho Rat ni okeru Enalapril no Koatsu Sayo", MEDICINE AND BIOLOGY, vol. 131, no. 6, 10 December 1995 (1995-12-10), pages 281 - 286, XP003027174 *
UCHIYAMA S. ET AL: "Tashurui Biryo Genso o Gan'yu suru Saldi Tierra no Rat Keiko Toyo ni yoru Kotsudoka Koka no Hatsugen", PROCEEDINGS OF THE ANNUAL MEETING OF THE PHARMACEUTICAL SOCIETY OF JAPAN, vol. 126, no. 3, 6 March 2006 (2006-03-06), pages 165, XP003027173 *
YAMAGUCHI M. ET AL: "Tashu Biryo Genso o Gan'yu suru Saldi Tierra no Sesshu wa Tonyobyo Narabini Kansetsuen Adjuvant Rat no Kotsugensho o Yokusei suru", BIOMED. RES. TRACE ELEMENTS, vol. 18, no. 2, 1 June 2007 (2007-06-01), pages 163, XP003027175 *

Also Published As

Publication number Publication date
JP5194022B2 (en) 2013-05-08
JPWO2009044439A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
WO2010068082A8 (en) Foaming composition for high temperature and salinity
BRPI0519316A2 (en) herbicidal aqueous composition, and process for the preparation of a composition
AR056055A1 (en) CRYSTALLINE AND HYDRATIC COMPLEXES OF 1-CHLORINE-4- (BETA-D-GLUCOPIRANOS-1-IL) -2- (4-ETINIL-BENCIL) -BENZENE
WO2007146741A3 (en) Salt replacing composition, process for its preparation and food systems containing such composition
WO2006134361A3 (en) Agricultural composition
WO2009004512A3 (en) Solidification matrix including a salt of a straight chain saturated mono-, di-, or tri- carboxylic acid
WO2007091037A3 (en) Metal-containing virucidal compositions and uses
TW200724166A (en) Wrinkle-improving agent
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
WO2008126678A1 (en) Seasoning composition, salty taste-like taste enhancer and method for enhancing salty taste-like taste of food and drink
TW200631574A (en) Liquid seasoning
BRPI0813712A2 (en) SOLUBLE FORMULATION, WATER HERBICIDE COMPOSITION, METHOD TO CONTROL UNDESIRABLE VEGETATION, AND, QUINCLORAC AMMONY SALT
MY163134A (en) Composition containing riboflavin and sesamin-class compounds
MX2013006824A (en) Stock cube.
RU2018126051A (en) WATER BINDER COMPOSITION
MX2009007265A (en) Salts, aqueous liquid compositions containing salts of s-(+)-abscisic acid and methods of their preparation.
AR075097A1 (en) CRYSTAL POLYMAL SALES AND FORMS OF [4- (6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-IL) -PENYL] -5-CHLORINE-THIOPHEN-2- IL-SULFONIL UREA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD TO PREPARE THEM AND USE OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATE
PL2120601T3 (en) Free-flowing gelatin composition
WO2009044439A1 (en) Composition for preventing or treating liver disease
AU2003283823A1 (en) Ergogenic multivitamin-mineral energy supplement for the prevention of muscle fatigue
GT201000235A (en) A PRODUCT TO INCREASE PHOTOSYNTHESIS
CN106892466A (en) A kind of artificial seawater formula
WO2008078759A1 (en) Composition comprising carnitine salt and ph-adjusting agent
UA106580C2 (en) The pharmaceutically acceptable salts timodepresinu and method for their production
WO2007025764A3 (en) Pharmaceutical formulations for salts of monobasic acids comprising clopidogrel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07828920

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009535898

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07828920

Country of ref document: EP

Kind code of ref document: A1